Search

everythinglearnresearchcommunity

for

Search:↓

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Lowering testosterone speeds up wound healing in male mice.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Hair microscopy is a simple and cost-effective method to help diagnose systemic diseases in children.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Severe acne in a young girl may indicate underlying hormonal issues.